Becton Dickinson and Company ($BDX) Stock Forecast: Down 5.0% Today

What is Becton Dickinson and Company?

Becton, Dickinson and Company (BDX) is a global medical technology company that specializes in the development and manufacturing of medical devices, instrument systems, and reagents. The company operates in two segments: BD Medical and BD Life Sciences.

Why is Becton Dickinson and Company going down?

BDX stock is down 5.0% on Nov 7, 2024 19:26

• Despite strong fourth-quarter sales and exceeding revenue estimates, BDX faced a downturn likely attributed to concerns over lower sales expectations in China and market dynamics in the bioscience and pharma sectors.
• The introduction of the BD IO Vascular Access System, designed for quick vascular access in critical care scenarios, did not offset the prevailing market sentiment towards the stock.
• Investors may be evaluating BDX against other companies like MMSI, potentially leading to selling pressure on the stock.
• Although positive earnings surprises were noted, they may not have been enough to counter broader market worries, contributing to BDX's bearish performance despite its robust financial results.

BDX Price Chart

BDX Technical Analysis

BDX News

Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth - Becton Dickinson ( NYSE:BDX )

On Thursday, Becton, Dickinson and Company BDX reported fourth-quarter sales of $5.44 billion, up 6.9% year over year ( +7.4% currency-neutral and 6.2% organic ) , beating the consensus of $5.38 billion.

https://www.benzinga.com/news/earnings/24/11/41818808/global-medical-tech-becton-dickinson-expects-lower-china-sales-bioscience-and-pharma-market-dynamic

BDX or MMSI: Which Is the Better Value Stock Right Now?

BDX vs. MMSI: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2366648/bdx-or-mmsi-which-is-the-better-value-stock-right-now

Becton Dickinson ( BDX ) Q4 Earnings and Revenues Surpass Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 1.06% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2366010/becton-dickinson-bdx-q4-earnings-and-revenues-surpass-estimates

Insights Into Becton Dickinson ( BDX ) Q4: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

https://www.zacks.com/stock/news/2363282/insights-into-becton-dickinson-bdx-q4-wall-street-projections-for-key-metrics

BDX Stock Declines Despite Launching BD IO Vascular Access System

BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.

https://www.zacks.com/stock/news/2362853/bdx-stock-declines-despite-launching-bd-io-vascular-access-system

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 19.9% Today

Arweave ($AR) Crypto Forecast: Up 15.4% Today

TRON ($TRX) Crypto Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 10.5% Today

Aave ($AAVE) Crypto Forecast: Up 5.2% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 7.6% Today

Algorand ($ALGO) Crypto Forecast: Up 35.9% Today

Stellar ($XLM) Crypto Forecast: Up 51.8% Today

Avalanche ($AVAX) Crypto Forecast: Up 21.0% Today

Cardano ($ADA) Crypto Forecast: Up 24.0% Today

Becton Dickinson and Company Price History

07.10.2024 - BDX Stock was down 5.0%

• Despite strong fourth-quarter sales and exceeding revenue estimates, BDX faced a downturn likely attributed to concerns over lower sales expectations in China and market dynamics in the bioscience and pharma sectors.
• The introduction of the BD IO Vascular Access System, designed for quick vascular access in critical care scenarios, did not offset the prevailing market sentiment towards the stock.
• Investors may be evaluating BDX against other companies like MMSI, potentially leading to selling pressure on the stock.
• Although positive earnings surprises were noted, they may not have been enough to counter broader market worries, contributing to BDX's bearish performance despite its robust financial results.

26.05.2023 - BDX Stock was up 1.2%

• BDX had a strong bullish movement due to the announcement of the sale of its Surgical Instrumentation platform to STERIS for $540 million.
• The sale will allow BDX to allocate the cash proceeds for capital allocation priorities for a "durable growth profile."
• This move could potentially lead to a shift in focus towards other areas of the medical technology industry for BDX.

09.10.2023 - BDX Stock was down 5.5%

• BDX reported Q4 earnings that decreased from last year and missed Street estimates, which could have contributed to the bearish movement.
• The company's earnings totaled $108 million, which fell short of expectations.
• Despite revenue topping estimates, BDX missed estimated earnings by 0.29%.
• Becton, Dickinson also announced a dividend increase, but this news did not seem to offset the negative sentiment surrounding the earnings miss.

30.05.2023 - BDX Stock was up 2.3%

• BDX stock had a strong bullish movement today.
• The stock was downgraded to "Hold" by StockNews.com.
• BDX is considered one of the most undervalued blue-chip stocks to buy.
• Over the past 20 years, BDX has outperformed the market, with an average annual return of 9.93%.
• Combined assessment:
• Despite the downgrade by StockNews.com, BDX had a strong bullish movement today, possibly driven by the overall positive sentiment in the stock market. The stock is considered undervalued and has a history of outperforming the market, which could have attracted investors.

03.04.2024 - BDX Stock was down 0.5%

• Despite reporting strong second-quarter sales and surpassing earnings and revenue estimates, BDX's stock experienced a bearish movement.
• The overall bullish market sentiment did not positively impact BDX on Thursday, hinting at a specific factor affecting the stock.
• Investors may have been concerned about future growth prospects or external factors despite the positive financial results.
• The contrast between optimistic analyst outlook and market movement implies underlying issues influencing investor sentiment towards BDX.

11.09.2023 - BDX Stock was down 1.8%

• The bearish movement in BDX today could be attributed to the following factors:
• 1. SevenBridge Financial Group LLC reducing its stake in BDX: The news of a major shareholder decreasing its holdings in the company might have raised concerns among investors, leading to a sell-off and downward pressure on the stock price.
• 2. Mixed analyst sentiment: Despite Becton, Dickinson and Company's solid growth in Q3 driven by strong demand for its products, there might be some mixed opinions among analysts regarding the stock's future performance. This uncertainty could have contributed to the bearish movement.
• 3. Overall market sentiment: It is also important to consider the broader market conditions. If there was a general bearish sentiment in the market today, it could have influenced the downward movement of BDX along with other stocks.
• Please note that these assessments are based on the provided articles and may not capture all the factors influencing the stock's movement.

05.08.2023 - BDX Stock was down 1.2%

• The bearish movement in BDX's stock today could be attributed to the following factors:
• 1. Non-pharma healthcare focus: The article highlights the potential gains in non-pharma healthcare stocks. As BDX is a medical device manufacturer, it may not have been the top choice for investors seeking pharmaceutical-related investments, leading to a decrease in demand for the stock.
• 2. Emerging themes in healthcare: The article mentions that utilization, digital healthcare, managed care, and medical services are emerging trends in the healthcare industry. If investors perceive BDX's products to be less aligned with these trends, it could have contributed to the bearish movement.
• 3. Analyst ratings: The article mentions that the recommended stocks are rated "Overweight" or better by analysts. If BDX's stock does not receive a similarly positive rating, it could have influenced investor sentiment and contributed to the bearish movement.

03.05.2024 - BDX Stock was up 2.4%

• BDX stock experienced a bullish movement after announcing the acquisition of Edwards Lifesciences' critical care business for $4.2 billion.
• The market reacted positively to this strategic move, as it expands BDX's portfolio and strengthens its position in the healthcare industry.
• The acquisition is seen as a smart investment by BDX to enhance its offerings and potentially drive future growth in the medical technology sector.
• This news reflects investor confidence in BDX's strategic decisions and long-term prospects, contributing to the bullish movement in the stock price.

10.06.2024 - BDX Stock was up 0.1%

• The bullish movement in BDX stock today could be attributed to the positive performance comparison with its competitors in the Health Care Equipment & Supplies industry.
• Investors may be reacting favorably to the extensive industry analysis that highlights Boston Scientific's strong market standing, growth prospects, and key financial metrics.
• The market may be optimistic about Boston Scientific's innovative products for medical procedures, such as angioplasty, cardiac rhythm management, and chronic pain treatment, which could drive future growth and profitability.